Clinical Study

Comparison of Glycomacropeptide with Phenylalanine Free-Synthetic Amino Acids in Test Meals to PKU Patients: No Significant Differences in Biomarkers, Including Plasma Phe Levels

Table 3

Patient data, all with classic PKU: age, mutations, height, weight, BMI, and usual AA supplement.

Patient ID#AgeMutation 1Mutation 2PhenotypeHeight (cm)Weight (kg)BMIUsual AA product

148c.1315+1G>A1c.1315+1G>A1Classic PKU1698530PreKUnil tablets
227c.1315+1G>A1c.1222C>T2Classic PKU1746220XPhe energy
318c.842C>T3c.1315+1G>A1Classic PKU1717526Avonil powder
416c.1222C>T2c.1315+1G>A1Classic PKU1714716Avonil tablets
538c.1315+1G>A1c.1222C>T2Classic PKU1797925PreKUnil tablets
646c.814G>T4c.1222C>T2Classic PKU1739431PreKUnil tablets
734c.473G>A5c.1315+1G>A1Classic PKU1625320PreKUnil tablets
839c.1222C>T2c.1222C>T2Classic PKU16287.533Avonil tablets

1(IVS12+1G>A); 2p.R408W; 3p.E280K; 4p.G272X; 5p.R158Q.